Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.BridgeBio has trimmed its gene therapy budget after data on an adrenal gland medicine fell short of expectations. Gene therapy startup Vironexis has received approval for a first-of-its-kind trial testing a cancer drug delivered via adeno-associated viruses. Candid, with $370 million in funding, is aiming to prove the worth of bispecifics in autoimmune disease treat...